“The primary focus of any medical cannabis legalization law must be providing safe and convenient access to patients in order to improve their quality of life; it should not be about increasing revenue streams for state lawmakers.”
“As legal access continues to expand, one would expect the cannabis substitution effect to grow even more pronounced in the future.”
“Rather than embracing Oklahoma’s robust medical cannabis industry, politicians have instead sought to abruptly tap the breaks. This legislation is largely a solution in search of a problem and it is directly in conflict with the ‘free market’ principles so often espoused by those elected officials on the right side of the aisle.”
“This expansion is long overdue,” said NORML’s Deputy Director Paul Armentano. “High prices and the lack of convenient access provide significant barriers to Ohio’s patient community. Hopefully, the addition of these licensed operators will better address patients’ growing demands.”
The Governor has proposed an amendment in the nature of a substitute to SB 591 which would create two new misdemeanors for personal marijuana possession.
“These legislative improvements will bring great relief to the thousands of Virginians waiting to access the medical cannabis program,” said JM Pedini, NORML’s Development Director and the Executive Director of Virginia NORML.
“Seventy percent of voters approved this right at the ballot box and it is reassuring to see that a majority of lawmakers, and the Governor, ultimately decided to respect the voters’ decision.”
“It is encouraging to see the Court take the position that medical cannabis ought to be tax exempt in a manner like other medications. Patients, many of whom may be on disability or a fixed income, should not been seen by lawmakers as a source of tax revenue.”